DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Glioblastoma

Glioblastoma

  • Central Nervous System Tumors General ~1% of Tumors in Adults, but ~25% of Malignancies in Children (Only 2Nd to Leukemia)

    Central Nervous System Tumors General ~1% of Tumors in Adults, but ~25% of Malignancies in Children (Only 2Nd to Leukemia)

  • Inhibition of Mir-1193 Leads to Synthetic Lethality in Glioblastoma

    Inhibition of Mir-1193 Leads to Synthetic Lethality in Glioblastoma

  • GBM (English)

    GBM (English)

  • Meningioma ACKNOWLEDGEMENTS

    Meningioma ACKNOWLEDGEMENTS

  • The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy

    The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy

  • Rehabilitation of Adult Patients with Primary Brain Tumors: a Narrative Review

    Rehabilitation of Adult Patients with Primary Brain Tumors: a Narrative Review

  • Information Sheet 4: High-Grade Glioma Brain Tumours and Treatment Options

    Information Sheet 4: High-Grade Glioma Brain Tumours and Treatment Options

  • Neurofibromatosis Type 1 and Type 2 Associated Tumours: Current Trends in Diagnosis and Management with a Focus on Novel Medical Therapies

    Neurofibromatosis Type 1 and Type 2 Associated Tumours: Current Trends in Diagnosis and Management with a Focus on Novel Medical Therapies

  • Proceedings from the 2009 NF Conference: New Frontiers Joseph L

    Proceedings from the 2009 NF Conference: New Frontiers Joseph L

  • Clinical and Genetic Patterns Ofneurofibromatosis 1 and 2

    Clinical and Genetic Patterns Ofneurofibromatosis 1 and 2

  • Current FDA-Approved Therapies for High-Grade Malignant Gliomas

    Current FDA-Approved Therapies for High-Grade Malignant Gliomas

  • Current Understanding of Neurofibromatosis Type 1, 2, And

    Current Understanding of Neurofibromatosis Type 1, 2, And

  • Genetic Testing for Neurofibromatosis and Related Disorders

    Genetic Testing for Neurofibromatosis and Related Disorders

  • Inhibition of TRAIL-Induced Apoptosis by Bcl-2 Overexpression

    Inhibition of TRAIL-Induced Apoptosis by Bcl-2 Overexpression

  • End-Of-Life Care for Brain Tumor Patients Manual for Health Care Providers

    End-Of-Life Care for Brain Tumor Patients Manual for Health Care Providers

  • Glioblastoma Masquerading As a Parafalcine Meningioma: a Pathological Surprise!

    Glioblastoma Masquerading As a Parafalcine Meningioma: a Pathological Surprise!

  • Malignant Transformation of Low Grade Gliomas Into Glioblastoma a Series of 10 Cases and Review of the Literature

    Malignant Transformation of Low Grade Gliomas Into Glioblastoma a Series of 10 Cases and Review of the Literature

  • Glioblastoma and Glioblastoma with Oligodendroglial Component: a Histological and Prognostic Overview Runing Head: Pathology and GBM and GBMO

    Glioblastoma and Glioblastoma with Oligodendroglial Component: a Histological and Prognostic Overview Runing Head: Pathology and GBM and GBMO

Top View
  • Commentary: Current Status of Intratumoral Therapy for Glioblastoma Gregory D
  • A Guide for Journalists on Glioblastoma and Its Treatment Contents Overview Section 1 Glioblastoma Section 2 Epidemiology and Prognosis Section 3 Treatment References
  • Dura Based Rhabdoid Glioblastoma Masquerading As Meningioma
  • Meningiomas and Schwannomas in Neurofibromatosis 2
  • The New WHO Classification of Brain Tumors and Molecular Profiling In
  • Recurrent Glioblastoma: from Molecular Landscape to New Treatment Perspectives
  • About Brain Tumors: a Primer for Patients and Caregivers
  • Brainstem Glioblastoma Multiforme in a Patient with NF1 JOHN T
  • How Tissue Fluidity Influences Brain Tumor Progression
  • Myelofibrosis Glioblastoma
  • Applied Precision Cancer Medicine in Neuro-Oncology H
  • New Deletion in Low-Grade Oligodendroglioma at the Glioblastoma Suppressor Locus on Chromosome 10Q25-26
  • Intraventricular Glioblastoma
  • Glioblastoma & Anaplastic Astrocytoma
  • The Misclassification of Diffuse Gliomas: Rates and Outcomes J
  • Glioblastoma Factsheet
  • Peptide Dendrimers with Non-Symmetric Bola Structure Exert Long Term Effect on Glioblastoma and Neuroblastoma Cell Lines
  • NCCN Guidelines for Patients Brain Cancer: Gliomas


© 2024 Docslib.org    Feedback